NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes
NCT00095446
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
513
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Interventions
DRUG:
insulin aspart
Sponsor
Novo Nordisk A/S